ArticleLasers in medical science2025
Selective laser trabeculoplasty positively impacts long-term intraocular pressure fluctuation in untreated open-angle glaucoma patients.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We sought to investigate the influence of selective laser trabeculoplasty (SLT), as a primary treatment option, on long-term (between visits) intraocular pressure (IOP) variation parameters in eyes with ocular hypertension (OH) or open-angle glaucoma (OAG). This multicenter, real-world data based, retrospective study consecutively enrolled untreated patients that had undergone a single SLT treatment and had a minimum follow-up of 24 months post-SLT. All included patients had to have at least 3 IOP measurements before (within 90 days) the SLT procedure. Patients requiring any glaucoma medication or procedure during the follow-up were excluded. Main outcome measurements were the comparison between pre and post-SLT IOP variation parameters (mean, peak and IOP fluctuation), based on data collected from each follow-up visit. Among 835 patients that had undergone SLT between January 2011 and December 2020, 67 eyes from 67 patients (mean age, 60.5 ± 16.8 years) fulfilled all study inclusion/exclusion criteria and were included in the final analysis. After 24 months of follow-up, mean baseline IOP was significantly reduced from 19.1 ± 2.9 mmHg to 13.6 ± 2.1 following SLT (IOP change, 29%; p < 0.001). Regarding IOP variation parameters, mean baseline IOP peak was significantly reduced from 20.7 ± 3.5 mmHg to 15.1 ± 2.5 mmHg (IOP change, 27%; p < 0.001). In addition, mean baseline IOP fluctuation (based on within subject standard deviation values) was significantly reduced from 1.8 ± 0.1 mmHg to 1.2 ± 0.1 mmHg (IOP change, 33%; p < 0.001). Our results, derived from real world data, suggest that SLT not only effectively reduces mean IOP values, but also positively impacts (by approximately 30%) both IOP fluctuation and peak. Even though our findings provide additional support for the use of SLT on clinical practice, they certainly warrant confirmation by a prospective study.
Indexed as
Identifiers
40958038What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.